About Bionabu
Bionabu is a Clinical Trial Integrity Platform that combines patient education, content governance and protocol governance into one connected system — so what a protocol intends is what actually happens, from first patient contact to inspection.
Trials don't usually fail on the science. They fail in the gaps.
Between what a participant is told and what they understand. Between an approved document and the version actually in use at site. Between a protocol deviation happening and anyone catching it. Each gap is small on its own — but together they erode data validity, inspection outcomes and participant trust.
Bionabu closes the loop. We build the working tools that carry one standard across the whole patient journey: prepare the patient, govern the content, control the deviations — connected, traceable, and inspection-ready.
That's PrepStoriesAI®, Vera Content™ and Vera Deviate™ working as one system — explained in full on the home page.
A platform is only half of it. The other half is people who've done the work.
Bionabu pairs AI with the Bionabu Reviewer Network™ — vetted clinical-research professionals, not random freelancers or generic translators. The AI does the first pass; people from the field make the judgement that actually protects patients and data.
- Consistency checks
- Reading level
- Terminology
- Clinical review
- Patient review
- Language & cultural review
Reviewers are drawn from the profession:
It's also how Bionabu grows the next generation of clinical-research specialists — the heritage the name was built on. Join the reviewer network →
We delivered the work by hand first. The platform formalises what we already know how to do.
Bionabu didn't start as software. It started as a method — sequencing patient communication across the clinical journey — delivered manually, study by study, until the pattern was proven. The platform is that hard-won operating model, made repeatable.
Burgstaller et al., Reimagining Informed Consent: AI Avatars in the Era of Complex Clinical Trials (Pharmaceutical Engineering, ISPE GAMP, 2025). The approach has since been applied in a US chronic kidney disease clinical study and in paediatric communication materials prepared for ethics-committee review at a leading European academic centre, with live pilots in Colombia and Spain.
Operator-led technology for clinical operations.
Most clinical-operations software is built by engineers, then sold to the people who actually run trials. Bionabu was built the other way around — by an operator who learned to code because the tools were failing her, and who knew exactly where they break because she had lived it.
Anyone can add AI. Our edge is the operational brain underneath it: years of real clinical-operations experience — the actual pain, the actual workarounds — encoded into how the product works. AI does the scale; an operator's judgement does the design.
It's the difference between a cockpit built by a pilot and one built by someone who has only read about flying. Sit inside Vera and you can feel it was made by someone who has done the job.
Ina Burgstaller
Founder & CEO, Bionabu®
"I learned to build software because I couldn't face another day in Excel and Word. I was sure there was a better way — so I built it."
Ina built Bionabu from inside the problem. After years running paediatric trial communication by hand — wrestling spreadsheets, documents and version chaos — she taught herself to build the tools she wished existed. That work became Visit Before the Visit™, the methodology for sequencing patient communication across clinical journeys, productised as PrepStoriesAI®. From there grew the conviction behind Bionabu: that trial integrity is a system problem — spanning patient understanding, content control and protocol conduct — and that it deserves connected, inspection-ready tools built by people who have actually done the job.
See where Bionabu fits your trial.
We'll map one of your studies to the system — and if it doesn't fit, we'll tell you that too.
Book a walkthrough →